MDBIF (TrivarX) Common Stock : $68.32 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is TrivarX Common Stock?

TrivarX's quarterly common stock increased from Dec. 2023 ($70.22 Mil) to Jun. 2024 ($70.76 Mil) but then declined from Jun. 2024 ($70.76 Mil) to Dec. 2024 ($68.32 Mil).

TrivarX's annual common stock declined from Jun. 2022 ($69.89 Mil) to Jun. 2023 ($68.32 Mil) but then increased from Jun. 2023 ($68.32 Mil) to Jun. 2024 ($70.76 Mil).

TrivarX Common Stock Historical Data

The historical data trend for TrivarX's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Common Stock Chart

TrivarX Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Common Stock

Get a 7-Day Free Trial

63.26

73.45

69.89

68.32

70.76

TrivarX Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Common Stock	Get a 7-Day Free Trial															67.63	68.32	70.22	70.76	68.32

TrivarX Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

TrivarX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

TRI:Australia

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.trivarx.com

TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.